Integrity Applications Signs Three Additional Distribution Agreements For Its Glucotrack® Model DF-F Glucose Monitoring Device

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ASHKELON, Israel--(BUSINESS WIRE)--First graph of release should read: Integrity Applications, Inc. (OTCQB:IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its wholly-owned subsidiary, Integrity Applications Ltd., into distribution agreements for the GlucoTrack device in Italy, Thailand and Uruguay. The distribution agreement with Italy represents the company’s first such agreement in a European Union member country. According to the International Diabetes Federation, a total of about 3.6 million people with diabetes live in Italy, 3.2 million people with diabetes live in Thailand and 144,000 people with diabetes live in Uruguay.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC